Siemens Healthineers ramps up production capacity

2020-05-27
Siemens Healthineers ramps up production capacity

Siemens Healthineers plans to ship more than 2.5 million molecular PCR tests per month worldwide as production capacity increases. Find here footage from our site in Marburg, Germany, to use for your broadcast.

CE-marked for sale in the EU. This test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21. U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Product availability may vary by country and is subject to regulatory requirements.